Drawing for BALIMEK

USPTO serial 86278551

BALIMEK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
CASSIDY, COLLEEN MULCRONE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BALIMEK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthmaACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 6, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 6, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 4, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2017EX5GSOU EXTENSION 5 GRANTED
Apr 27, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 22, 2017EXT5SOU EXTENSION 5 FILED
Mar 22, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 18, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 15, 2016EX4GSOU EXTENSION 4 GRANTED
Sep 21, 2016EXT4SOU EXTENSION 4 FILED
Sep 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 19, 2016EX3GSOU EXTENSION 3 GRANTED
Apr 11, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 11, 2016EXT3SOU EXTENSION 3 FILED
Mar 11, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 10, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 1, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2015EX2GSOU EXTENSION 2 GRANTED
Sep 30, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 24, 2015EXT2SOU EXTENSION 2 FILED
Sep 24, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2015DOCKASSIGNED TO EXAMINER
Mar 24, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2015EX1GSOU EXTENSION 1 GRANTED
Mar 22, 2015EXT1SOU EXTENSION 1 FILED
Mar 22, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 5, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2014DOCKASSIGNED TO EXAMINER
May 22, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2014NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance